Alan F. Rothfeld, MDProfessor of Practice
Areas of Expertise
Internal Medicine, Pulmonary and Critical Care Medicine, Clinical Pharmacology, Medical Quality Innovation, Behavioral Economics
Dr. Rothfeld received his bachelor's degree in biological sciences from Cornell University in Ithaca, NY, and his MD from Baylor College of Medicine in Houston, TX.
He completed a residency in internal medicine at Baylor Affiliated Hospitals and a fellowship in pulmonary medicine at the University of North Carolina at Chapel Hill. Dr. Rothfeld was in the private practice of the pulmonary and critical care medicine for 25 years and has served as a member of the faculty at the Keck School of Medicine of the University of Southern California since 1979, including as an assistant professor of medicine, clinical associate professor of medicine, and, currently, as a clinical professor of medicine.
He is also the medical director and an adjunct professor of respiratory therapy at Los Angeles Valley College, as well as the director of translational research at COPE Health Solutions, a leading, not-for-profit health care corporation based in Los Angeles. Since 2006, Dr. Rothfeld has also been the medical director of the Los Angeles-based QueensCare Family Clinics.
ALS 437: Clinical Pharmacology I
The course attempts to provide a general framework on which to fit future specialized knowledge encountered during a career in the various biomedical fields. Some of the subjects addressed are: underlying principles of pharmacology and clinical biology, assessing and weighing benefits and risks, how physicians select therapies for a given disorder, how side effects are assessed and dealt with, and how issues of cost and compliance are handled.ALS 438: Clinical Pharmacology II
The course provides overviews of disease categories, issues of cost, marketing, and the clinical trial process.
- Selected Publications
Bensadoun A, Rothfeld AF, The absorption of lipids in gallus domesticus. Proc Soc Exp Biol Med 1972;141:814.
Sher H, Banwell J, Rothfeld AF, Pasthophysiological response of rabbit jejunum to escherica coli enterotoxin. Gastroenterology 1973; 65:895.
Rothfeld AF, Bromberg P, New approaches to the management of pneumothorax. Hosp Med 1978;14:66.
Rothfeld AF, Nichols HP, Friedman M, Effects of positive end expiratory pressure on pulmonary tissue volume measurements obtained by a soluble gas rebreathing technique. Am Rev Resp Dis 1979; 119:386.
Friedman M, Rothfeld AF, Nichols, HP, Effects of varying inspired volume on inert gas rebreathing. Fed Proc 1979; 11:1336.
Friedman M, Wilkins S, Rothfeld AF, et al, Effects of ventilation perfusion imbalance on air-gas rebreathing variables. J App Phys 1984; 56:364.
Rothfeld AF, Friedman M, Changes in pulmonary tissue volume during cardiogenic pulmonary edema. J App Physiol 1980;52:355.
Rothfeld AF, Tinker C, Glasberg M, Physiologic defects in 100 consecutive patients on their third day of mechanical ventilation. Am Rev Resp Dis 1988; 137:473.
Rothfeld AF, Tinker C, Factors contributing to ventilator dependence in unselected patients on mechanical ventilation for three days. Am Rev Resp Dis 1989; 139:531.
Rothfeld AF, Van Gundy K, The measurement of expiratory resistance in mechanically ventilated patients. Chest 1989; 96:254s. (presentation)
Rothfeld AF, Tuchschmidt J, The duration of mechanical ventilation. (presentation) Am Rev Resp Dis 1989; 139:531.
Rothfeld AF, Flanigan K, Comparison of two methods for measuring expiratory resistance in intubated patients. Chest 1993;104:47.
Rothfeld AF, Defining respiratory failure in mechanically ventilated patients, Chest 1994;106:648.
Rothfeld AF, Chao DC, Scheinhorn DJ, LaBree LD, Vd/Vt as a predictor of weaning outcome in MICU patients. Chest 1995; 108:135s (invited presentation)
Rothfeld AF, Stickley A, A Program to limit urinary catheter use at an Acute Care Hospital, American Journal of Infection Control 2010;38:568-71.Culbert MB & Rothfeld AF, Mediating medical malpractice cases. The Advocate October 2010; 32:84-87.
He is engaged in translational research that focuses on behavioral economics and its role in the adoption of best practices into clinical care and the reduction in harm done by medical care, especially with regard to hospital-acquired conditions, such as infections and drug-induced problems.
Current projects include an Antibiotic Stewardship program to rationalize antibiotic use at a large urban hospital, as well as several projects aimed at reducing complications related to medical devices.
Another current project is designed to use behavioral economics to reduce inappropriate antibiotic use in outpatient clinics. This approach may have broad application in other areas of health care delivery.
|Alan F. Rothfeld, MD|
|Location:||Building 517, Room B142|